Cargando…

Evaluation of potential anti-COVID-19 therapies

Detalles Bibliográficos
Autores principales:	Box, Clare L, J Thompson, Kevin S
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Newlands Press Ltd 2020
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7714043/ http://dx.doi.org/10.4155/fdd-2020-0029

Ejemplares similares

Anti-cytokine Therapy in Hospitalized Patients with COVID-19: The Jury is Out
por: Garg, Sunil Kumar
Publicado: (2022)

The Disillusioned Comfort with COVID-19 and the Potential of Convalescent Plasma and Cell Therapy
por: Borlongan, Mia C., et al.
Publicado: (2020)

Evaluating the potential impact of interruptions to neglected tropical disease programmes due to COVID-19
por: Hollingsworth, T Déirdre, et al.
Publicado: (2021)

Timing of COVID-19 Vaccine in the Setting of Anti-CD20 Therapy: A Primer for Nephrologists
por: Kant, Sam, et al.
Publicado: (2021)

Colchicine, an anti-rheumatic agent, as a potential compound for the treatment of COVID-19
por: Perricone, Carlo, et al.
Publicado: (2020)

Covid-19 — The Search for Effective Therapy
por: Baden, Lindsey R., et al.
Publicado: (2020)

Electrophysiology and COVID-19: An era of new potential
por: Gleva, Marye J.
Publicado: (2020)

Immune radiobiology
por: Vanpouille-Box, Claire
Publicado: (2021)

Biologic Therapy in COVID-19
por: González-Gay, Miguel A., et al.
Publicado: (2021)

Les vaccins à ARN anti-COVID-19
por: Galibert, F.
Publicado: (2021)

Consensus Guidelines for the Management of Melanoma during the COVID-19 Pandemic: Surgery, Systemic Anti-cancer Therapy, Radiotherapy and Follow-up
por: Nahm, S.H., et al.
Publicado: (2021)

Call for Papers on potential toxic effects of COVID-19 vaccines
por: Domingo, José L.
Publicado: (2022)

The Utility of Anti-Covid-19 Desks in Italy, Doubts and Criticism
por: Bergamin, Marco, et al.
Publicado: (2020)

The Potential for Repurposing Anti-TNF as a Therapy for the Treatment of COVID-19
por: Robinson, Philip C., et al.
Publicado: (2020)

COVID-19, museums, and art therapy
por: Charlier, P.
Publicado: (2021)

Impact of COVID-19 therapy on hyperglycemia
por: Parise, Rachel, et al.
Publicado: (2022)

Update on Anti-EGFR Therapy
por: Chua, Daniel, et al.
Publicado: (2009)

Evaluation of long-term COVID-19
por: Kiefer, Michael C., et al.
Publicado: (2021)

Anthelmintics as Potential Anti-Cancer Drugs?
por: Heo, Dae Seog
Publicado: (2020)

Adipose Stem Cells (ASCs) and Stromal Vascular Fraction (SVF) as a Potential Therapy in Combating (COVID-19)-Disease
por: Gentile, Pietro, et al.
Publicado: (2020)

Predicting the future of anti-tumor necrosis factor therapy
por: Verweij, Cornelis L
Publicado: (2009)

Endothelial dysfunction in COVID-19: A potential predictor of long-COVID?
por: Seitz, Andreas, et al.
Publicado: (2022)

PCR detection and new therapies for COVID-19
por: Iwata, Takanori
Publicado: (2020)

Home Nitric Oxide Therapy for COVID-19
por: Alvarez, Roger A., et al.
Publicado: (2020)

Digital physical therapy in the COVID-19 pandemic
por: Dantas, Lucas Ogura, et al.
Publicado: (2020)

Covid-19 challenges to immune investigations and therapies
por: Talmadge, James E., et al.
Publicado: (2021)

Therapies for COVID-19: A Disorganized Approach
por: Somberg, John
Publicado: (2021)

Current Research on Antioxidant, Anti-Inflammatory and Anti-Obesity Potential of Food Extracts
por: Rivero-Pino, Fernando, et al.
Publicado: (2023)

Anti-Inflammatory Therapy in Diabetic Retinopathy
por: Zorena, Katarzyna
Publicado: (2014)

Natural Products in Anti-Obesity Therapy
por: Conforti, Filomena, et al.
Publicado: (2016)

COVID 19: Re-evaluation of Interventional Radiology
por: Uberoi, Raman, et al.
Publicado: (2021)

COVID-19 in children: patiently and critically evaluate the scientific evidence
por: Ritz, Nicole, et al.
Publicado: (2020)

Anti-IL6R role in treatment of COVID-19-related ARDS
por: Buonaguro, Franco Maria, et al.
Publicado: (2020)

Response of the multiple sclerosis community to COVID-19
por: Ciccarelli, Olga, et al.
Publicado: (2020)

Ivermectin may be a clinically useful anti-inflammatory agent for late-stage COVID-19
por: DiNicolantonio, James J, et al.
Publicado: (2020)

To immunosuppress: whom, when and how? That is the question with COVID-19
por: Winthrop, Kevin L, et al.
Publicado: (2020)

Rheumatology and COVID-19 at 1 year: facing the unknowns
por: Calabrese, Leonard, et al.
Publicado: (2021)

Integrative Cancer Therapies: Learning From COVID-19
por: Block, Keith I.
Publicado: (2020)

Tocilizumab for Covid-19 — The Ongoing Search for Effective Therapies
por: Huang, Edmund, et al.
Publicado: (2020)

Unmet need for COVID-19 therapies in community settings
por: The Lancet Infectious Diseases
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_k2726vaij1pm9fbddkga3677f4